Cargando…

The Role of Response-Shift in Studies Assessing Quality of Life Outcomes Among Cancer Patients: A Systematic Review

Objective: Response-shift has been cited as an important measurement consideration when assessing patient reported quality of life (QoL) outcomes over time among patients with severe chronic conditions. Here we report the results of a systematic review of response shift in studies assessing QoL amon...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilie, Gabriela, Bradfield, Jillian, Moodie, Louise, Lawen, Tarek, Ilie, Alzena, Lawen, Zeina, Blackman, Chloe, Gainer, Ryan, Rutledge, Robert D. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710367/
https://www.ncbi.nlm.nih.gov/pubmed/31482068
http://dx.doi.org/10.3389/fonc.2019.00783
_version_ 1783446335869943808
author Ilie, Gabriela
Bradfield, Jillian
Moodie, Louise
Lawen, Tarek
Ilie, Alzena
Lawen, Zeina
Blackman, Chloe
Gainer, Ryan
Rutledge, Robert D. H.
author_facet Ilie, Gabriela
Bradfield, Jillian
Moodie, Louise
Lawen, Tarek
Ilie, Alzena
Lawen, Zeina
Blackman, Chloe
Gainer, Ryan
Rutledge, Robert D. H.
author_sort Ilie, Gabriela
collection PubMed
description Objective: Response-shift has been cited as an important measurement consideration when assessing patient reported quality of life (QoL) outcomes over time among patients with severe chronic conditions. Here we report the results of a systematic review of response shift in studies assessing QoL among cancer patients. Methods: A systematic review using MEDLINE, EMBASE, and PsychINFO along with a manual search of the cited references of the articles selected, was conducted. A quality review was performed using STROBE criteria and reported according to PRISMA guidelines. Results: A systematic review of 1,487 records published between 1,887 and December 2018 revealed 104 potentially eligible studies, and 35 studies met inclusion criteria for content and quality. The most common cancer patient populations investigated in these studies were breast (18 studies), lung (14 studies), prostate (eight studies), and colorectal (eight studies). Response shift was identified among 34 of the 35 studies reviewed. Effect sizes were reported in 17 studies assessing QoL outcomes among cancer patients; 12 of which had negligible to small effect sizes, four reported medium effect sizes which were related to physical, global QoL, pain, and social (role) functioning and one reported a large effect size (fatigue). The most prevalent method for assessing response shift was the then-test, which is prone to recall bias, followed by the pre-test and post-test method. Given the heterogeneity among the characteristics of the samples and designs reviewed, as well as the overall small to negligible effect sizes for the effects reported, conclusions stating that changes due to internal cognitive shifts in perceived QoL should account for changes observed in cancer patients' QoL outcomes should be interpreted with caution. Conclusion: Further work is needed in this area of research. Future studies should control for patient characteristics, time elapsed between diagnosis and baseline assessment and evaluate their contribution to the presence of response shift. Time between assessments should include short and longer periods between assessments and evaluate whether the presence of response shift holds over time. Possible avenues for inquiry for future investigation are discussed.
format Online
Article
Text
id pubmed-6710367
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67103672019-09-03 The Role of Response-Shift in Studies Assessing Quality of Life Outcomes Among Cancer Patients: A Systematic Review Ilie, Gabriela Bradfield, Jillian Moodie, Louise Lawen, Tarek Ilie, Alzena Lawen, Zeina Blackman, Chloe Gainer, Ryan Rutledge, Robert D. H. Front Oncol Oncology Objective: Response-shift has been cited as an important measurement consideration when assessing patient reported quality of life (QoL) outcomes over time among patients with severe chronic conditions. Here we report the results of a systematic review of response shift in studies assessing QoL among cancer patients. Methods: A systematic review using MEDLINE, EMBASE, and PsychINFO along with a manual search of the cited references of the articles selected, was conducted. A quality review was performed using STROBE criteria and reported according to PRISMA guidelines. Results: A systematic review of 1,487 records published between 1,887 and December 2018 revealed 104 potentially eligible studies, and 35 studies met inclusion criteria for content and quality. The most common cancer patient populations investigated in these studies were breast (18 studies), lung (14 studies), prostate (eight studies), and colorectal (eight studies). Response shift was identified among 34 of the 35 studies reviewed. Effect sizes were reported in 17 studies assessing QoL outcomes among cancer patients; 12 of which had negligible to small effect sizes, four reported medium effect sizes which were related to physical, global QoL, pain, and social (role) functioning and one reported a large effect size (fatigue). The most prevalent method for assessing response shift was the then-test, which is prone to recall bias, followed by the pre-test and post-test method. Given the heterogeneity among the characteristics of the samples and designs reviewed, as well as the overall small to negligible effect sizes for the effects reported, conclusions stating that changes due to internal cognitive shifts in perceived QoL should account for changes observed in cancer patients' QoL outcomes should be interpreted with caution. Conclusion: Further work is needed in this area of research. Future studies should control for patient characteristics, time elapsed between diagnosis and baseline assessment and evaluate their contribution to the presence of response shift. Time between assessments should include short and longer periods between assessments and evaluate whether the presence of response shift holds over time. Possible avenues for inquiry for future investigation are discussed. Frontiers Media S.A. 2019-08-20 /pmc/articles/PMC6710367/ /pubmed/31482068 http://dx.doi.org/10.3389/fonc.2019.00783 Text en Copyright © 2019 Ilie, Bradfield, Moodie, Lawen, Ilie, Lawen, Blackman, Gainer and Rutledge. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ilie, Gabriela
Bradfield, Jillian
Moodie, Louise
Lawen, Tarek
Ilie, Alzena
Lawen, Zeina
Blackman, Chloe
Gainer, Ryan
Rutledge, Robert D. H.
The Role of Response-Shift in Studies Assessing Quality of Life Outcomes Among Cancer Patients: A Systematic Review
title The Role of Response-Shift in Studies Assessing Quality of Life Outcomes Among Cancer Patients: A Systematic Review
title_full The Role of Response-Shift in Studies Assessing Quality of Life Outcomes Among Cancer Patients: A Systematic Review
title_fullStr The Role of Response-Shift in Studies Assessing Quality of Life Outcomes Among Cancer Patients: A Systematic Review
title_full_unstemmed The Role of Response-Shift in Studies Assessing Quality of Life Outcomes Among Cancer Patients: A Systematic Review
title_short The Role of Response-Shift in Studies Assessing Quality of Life Outcomes Among Cancer Patients: A Systematic Review
title_sort role of response-shift in studies assessing quality of life outcomes among cancer patients: a systematic review
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710367/
https://www.ncbi.nlm.nih.gov/pubmed/31482068
http://dx.doi.org/10.3389/fonc.2019.00783
work_keys_str_mv AT iliegabriela theroleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT bradfieldjillian theroleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT moodielouise theroleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT lawentarek theroleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT iliealzena theroleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT lawenzeina theroleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT blackmanchloe theroleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT gainerryan theroleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT rutledgerobertdh theroleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT iliegabriela roleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT bradfieldjillian roleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT moodielouise roleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT lawentarek roleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT iliealzena roleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT lawenzeina roleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT blackmanchloe roleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT gainerryan roleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview
AT rutledgerobertdh roleofresponseshiftinstudiesassessingqualityoflifeoutcomesamongcancerpatientsasystematicreview